Bioreactor systems are essentially required for stem cell bioprocessing
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cha, Jae Min | - |
dc.contributor.author | Lee, Min-Young | - |
dc.contributor.author | Hong, Jongin | - |
dc.date.available | 2019-08-09T08:00:49Z | - |
dc.date.issued | 2019-03 | - |
dc.identifier.issn | 2508-7940 | - |
dc.identifier.issn | 2508-7959 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/32802 | - |
dc.description.abstract | As stem cell technologies have rapidly advanced, the stem cell therapy market has been forecast to reach hundreds of millions of USD in market value within the next 5 years. Regulatory frameworks throughout the stem cell market have been concurrently established, which will encourage the advent of a variety of stem cell products in our society. Given the circumstances, stem cell bioprocessing has emerged as one of the most critical fields of research to address a number of issues that currently exist in manufacturing clinical-grade stem cells at an industrial scale. Highly specialized bioreactor designs are at the center of essentially required technologies in the field of stem cell bioprocessing, which ultimately aim for automated, standardized, traceable, cost-effective, safe, and regulatory-compliant manufacture of stem cell-based products. In this review, recently developed bioreactor designs to introduce important regulatory factors to three-dimensional stem cell culture are exemplified, and prerequisites for the ideal bioreactor systems for stem cell bioprocessing are discussed. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SUNGKYUNKWAN UNIV SCH MEDICINE | - |
dc.title | Bioreactor systems are essentially required for stem cell bioprocessing | - |
dc.type | Article | - |
dc.identifier.doi | 10.23838/pfm.2018.00128 | - |
dc.identifier.bibliographicCitation | PRECISION AND FUTURE MEDICINE, v.3, no.1, pp 19 - 23 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000468862100003 | - |
dc.citation.endPage | 23 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 19 | - |
dc.citation.title | PRECISION AND FUTURE MEDICINE | - |
dc.citation.volume | 3 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Bioreactors | - |
dc.subject.keywordAuthor | Cell culture techniques | - |
dc.subject.keywordAuthor | Clinical grade stem cells | - |
dc.subject.keywordAuthor | Industrial scale | - |
dc.subject.keywordAuthor | Stem cell bioprocessing | - |
dc.subject.keywordPlus | EXPANSION | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | HYPOXIA | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | esci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.